.png){kind=logo}
GC Asia
Glaxo drinks deep with $9bn bond as US brims with cash
It was another $30bn week in the all-guns-blazing US investment grade bond market, but the clear star of the show was the $9bn four tranche offering for UK pharmaceutical firm GlaxoSmithKline, which pulled a staggering $17.8bn of orders.
 |
Launched to fund a share buyback programme, the deal broke several US dollar high grade records.It was the largest corporate Yankee issue since British Telecom in 2000; the biggest corporate bond since WorldCom in 2001; and the largest ever corporate issue outside the telecom ...
Already a subscriber? Login
-
Latest news from Corporate Bonds
-
Suez shakes off Veolia noise to print zero coupon trade
04.30 PM -
AusNet rarity secures almost eight times euro demand
03.45 PM -
PMM: Dollar return pushes SSA subscription levels lower
01.15 PM -
UST volatility is a wake-up call for Asia’s bond market
09.30 AM -
Dr Peng extends dollar bond maturity again
09.15 AM
-
-
Latest news from Corporate Bonds
-
Suez shakes off Veolia noise to print zero coupon trade
04.30 PM -
AusNet rarity secures almost eight times euro demand
03.45 PM -
PMM: Dollar return pushes SSA subscription levels lower
01.15 PM -
UST volatility is a wake-up call for Asia’s bond market
09.30 AM -
Dr Peng extends dollar bond maturity again
09.15 AM
-
